Skip Navigation

JNCI Journal of the National Cancer Institute 2002 94(17):1338-1339; doi:10.1093/jnci/94.17.1338
© 2002 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Laden, F.
Right arrow Articles by Wolff, M. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Laden, F.
Right arrow Articles by Wolff, M. S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 94, No. 17, 1338-1339, September 4, 2002
© 2002 Oxford University Press

CORRESPONDENCE

 

RESPONSE: Re: 1,1-Dichloro-2,2-bis- (p-chlorophenyl)ethylene and Polychlorinated Biphenyls and Breast Cancer: Combined Analysis of Five U.S. Studies

Francine Laden, David J. Hunter, Mary S. Wolff

Affiliations of authors: F. Laden, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; D. J. Hunter, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, and Department of Epidemiology and the Center for Cancer Prevention, Harvard School of Public Health, Boston; M. S. Wolff, Division of Environmental and Occupational Medicine, Mount Sinai Medical Center, New York, NY.

Correspondence to: Francine Laden, Sc.D., Channing Laboratory, 181 Longwood Ave., Boston, MA 02115 (e-mail: francine.laden@channing.harvard.edu).

The first 10% of the full text of this article appears below.

Glustrom and colleagues question whether residual 2,2-bis(p-chlorophenyl)-1,1-dichloroethylene (DDE) and polychlorinated biphenyl (PCB) levels constitute an appropriate biomarker for determining the estrogenic component of organochlorine exposures. They suggest that hydroxylated metabolites of aromatic organochlorines would be more appropriate measures of exposure to estrogenic compounds. Our article and a host of epidemiologic . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Jpn J Clin OncolHome page
H. Tsuda, A. Naito, C. K. Kim, K. Fukamachi, H. Nomoto, and M. A. Moore
Carcinogenesis and Its Modification by Environmental Endocrine Disruptors: In Vivo Experimental and Epidemiological Findings
Jpn. J. Clin. Oncol., June 1, 2003; 33(6): 259 - 270.
[Abstract] [Full Text] [PDF]